跳至主要内容
临床试验/TCTR20230417002
TCTR20230417002尚未招募4 期

The efficacy and safety of Fractional Erbium:YAG assisting percutaneous absorption of triamcinolone acetonide in different dosage forms : A pilot Study

Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University0 个研究点目标入组 6 人开始时间: 2023年4月17日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • 1. Healthy Thai descendant
  • 2. Have healthy skin, i.e., the skin on the forearm is free of inflammation, infection, and dyspigmentation.
  • 3. Patients who voluntarily agree to participate in the study

排除标准

  • 1. Being pregnant, breastfeeding, or after giving birth for no more than 3 months
  • 2. Have open wounds, scars, infections or tattoos on the forearm
  • 3. Perform any skin treatment (e.g., tanning, laser) on the forearm within 4 weeks prior to the start of the study.
  • 4. Have a history of allergy to steroids
  • 5. Have photosensitive rash or sensitivity to light
  • 6. Have a history of using substances that affect wound healing, such as using steroids or smoking regularly

研究者

发起方
Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University

相似试验